ccc EU continues to allow bisphenol in baby dummies | Antidote Europe

More Press Releases

Patients are now the real guinea pigs

Antidote Europe welcomes recent French media reports warning the public about dangerous medicines.

BBC presenter Uhlenbroek joins scientists on campaign

The campaign’s report presents an immediate science strategy to end poisoning tests on non-human primates.

Making a molehill out of the Bisphenol A mountain

Antidote Europe has criticised the French government for taking very timid measures to ban the synthetic chemical bisphenol A (BPA). It makes no sense to protect nursing infants by banning the substance in baby bottles when their mothers are exposed to it on a daily basis — not to mention the effect on the foetuses of pregnant women.

Another warning about bisphenol A

Antidote Europe has re-issued its warning on bisphenol A, criticizing the French Food Safety Agency (AFSSA) on its confused and unclear public announcements regarding this chemical.

Antidote Europe receives achievement award

Antidote Europe was awarded the Pietro Croce prize.

Is Bisphenol A the new silent killer?

Antidote Europe has launched a public campaign regarding the dangers of bisphenol A and has duly informed the new president of the European Parliament.

Bisphenol A, a chemical time bomb?

It is difficult to understand why food safety agencies continue to place their trust in ambiguous animal data when human data is readily available. The fact that DES and BPA share striking similarities in their structures is extremely worrisome and lends weight to the possibility that BPA is a “chemical time bomb” in terms of our health.

EU directive lags woefully behind the science

With a crucial vote about to take place on Tuesday 31st March, by the Agriculture Committee (AGRI) of the European Parliament, Antidote Europe has written to all members of this committee, urging them to include a clause in the revised version of the 86/609 directive, to facilitate the adoption of any scientifically sound, non animal method, based on the “weight of evidence” principle. Such a clause would significantly increase the scope and application of non animal methods in practice.

EU cautioned not to use animal organs

Antidote Europe has issued an urgent caution against the idea of transplanting animal organs into people.

Authorities warned of Bisphenol A health risk

The results of our analysis of bisphenol A using toxicogenomics techniques have been conveyed to the French and European agencies for food safety and to Canadian Health Authorities.


Press Releases

EU continues to allow bisphenol in baby dummies



Mon 25 Aug 2008



According to EFSA, the exposure of the human foetus to bisphenol A would be negligible because the mother rapidly metabolizes and eliminates this substance from her body. This conclusion is in contradiction with basic pharmacokinetics knowledge.

At a time when the Canadian government seeks to ban bisphenol A (BPA), especially in baby items, EU authorities appear to want to look the other way. Research commissioned by the group Antidote Europe has revealed the toxic potential of BPA, and the group is therefore dismayed that the EU authorities choose to ignore the health warnings associated with cancer and endocrine disruption.

Based on studies conducted in rats, the European Food Safety Authority (EFSA) published 23 July 2008 what it considers to be a “Tolerable Daily Intake” (TDI) of the chemical, at 0.05mg per kilogram of bodyweight.

Despite acknowledging significant differences between humans and rodents, EFSA apparently chose to ignore data on BPA obtained in human cells, which Antidote Europe presented to it in May, to bring the TDI figure more into line with data relevant to humans.

In support of its recommendations, EFSA stressed the fact that “people metabolize and excrete BPA far more quickly than rodents”, and concluded that “the exposure of the human foetus to BPA would be negligible because the mother rapidly metabolises and eliminates BPA from her body”. This suggests that rapid metabolism of a chemical provides protection against adverse effects. However, many prescription drugs are also metabolized quickly in the body and eliminated in a matter of a few hours, yet are able to exert powerful pharmacological effects on the body.

We would therefore urge EFSA to base its recommendations on the risk posed by BPA to humans, on data obtained from human cell cultures to begin with, using methods that are now well established, in place of unreliable animal tests.